Kairos Pharma Investor Relations Material
Latest events
Study Update
Kairos Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kairos Pharma Ltd
Access all reports
Kairos Pharma Ltd is a biopharmaceutical company focused on the development of cancer therapies. The company is engaged in researching and advancing novel treatments targeting various types of cancer through immunotherapy, targeted therapy, and combination approaches. The company is headquartered in Los Angeles, California, and its shares are listed on the OTC markets.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
KAPA
Country
🇺🇸 United States